BofA Securities has upgraded Honeywell Technologies to Neutral from Underperform and significantly increased its price target, citing the industrial conglomerate's strong second-quarter results and accelerating order growth.
Apple is planning a significant expansion into the smart home market with a new AI-powered display, aiming to challenge competitors like Amazon and Google, according to a report from Bloomberg.
Cullinan Therapeutics will initiate a potentially registrational Phase 2 study for its acute myeloid leukemia drug, CLN-049, in Q3 2026 after receiving positive feedback from the U.S. FDA.
Clinical research organization ICON plc will integrate Anthropic's Claude AI into its operations to streamline clinical trials, a move that sent its stock up nearly 8%.
Visa shares climbed after the company announced a significant workforce reduction, a move investors view as a positive step to improve cost efficiency. The rally was further supported by recent analyst upgrades and anticipation for the company's quarterly earnings report.
The tech-heavy Nasdaq Composite fell at Tuesday's open, pressured by investor worries over high spending and competition in the AI chip sector ahead of key corporate earnings reports. The Dow Jones Industrial Average, however, posted gains.
The Beijing-based AI startup is reportedly discussing the development of a new, larger AI model, a move that would require securing more advanced Nvidia chips despite U.S. export restrictions targeting Chinese tech firms.
Wells Fargo lowered its rating on Levi Strauss to Equal Weight from Overweight, citing the stock's significant run-up and emerging concerns about margin execution, though it maintained its $25 price target.
The U.S. International Development Finance Corporation has committed initial funding to a rare earths project in Madagascar, a strategic move aimed at developing alternative sources for critical minerals largely controlled by China.
